Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia

Blood

Volumn 87, Issue 12, 1996, Pages 5251-5256

  Brisco, Michael J ^b   Hughes, Elizabeth ^b   Neoh, Sim H ^b   Sykes, Pamela J ^b   Bradstock, Kenneth ^b   Enno, Arno ^b   Szer, Jeffrey ^b   McCaul, Kieran ^b   Morley, Alexander A ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DNA; ETOPOSIDE; IMMUNOGLOBULIN HEAVY CHAIN; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CYTOGENETICS; DRUG RESISTANCE; FEMALE; GENE; GENE REARRANGEMENT; HUMAN; INTRATHECAL DRUG ADMINISTRATION; LEUKEMIA REMISSION; MALE; MINIMAL RESIDUAL DISEASE; ORAL DRUG ADMINISTRATION; PHILADELPHIA 1 CHROMOSOME; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RELAPSE; SURVIVAL;

EID: 0029950770     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.12.5251.bloodjournal87125251     Document Type: Article

References (35)

1. d'Auriol L, Macintyre E, Galibert F, Sigaux F: In vitro amplification of T cell receptor γ gene rearrangements: A new tool for the assessment of minimal residual disease in acute lymphoblastic leukemias. Leukemia 3:155, 1989
2. Hansen-Hagge TE, Yokota S, Bartram CR: Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor delta chain sequences. Blood 74:1762, 1989
3. Yamada M, Hudson S, Tournay O, Bittenbender S, Shane SS, Lange B, Tsujimoto Y, Caton AJ, Rovera G: Detection of minimal residual disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determinity region (CDR-III)-specific probes. Proc Natl Acad Sci USA 86:5123, 1989
4. Tycko B, Palmer JD, Link MP, Smith SD, Sklar J: Polymerase chain reaction amplification of rearranged antigen receptor genes using junction-specific oligonucleotides: Possible application for detection of minimal residual disease in acute lymphoblastic leukemia. Cancer Cells 7:47, 1989
5. Brisco MJ, Tan LW, Orsborn AM, Morley AA: Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B-lymphocyte clones in a polyclonal population. Br J Haematol 75:163, 1990
6. Macintyre EA, d'Auriol L, Duparc N, Leverger G, Galibert F, Sigaux F: Use of oligonucleotide probes directed against T cell antigen receptor gamma delta variable-(diversity)-joining junctional sequences as a general method for detecting minimal residual disease inn acute lymphoblastic leukemias. J Clin Invest 86:2125, 1990
7. Yamada M, Wasserman R, Lange B, Reichard BA, Womer RB, Rovera G: Minimal residual disease in childhood B-lineage lymphoblastic leukemia: Persistence of leukemic cells during the first 18 months of treatment. N Engl J Med 323:448, 1990
8. Jonsson OG, Kitchens RL, Scott FC, Smith RG: Detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin hypervariable region specific oligonucleotide probes. Blood 76:2072, 1990
9. Brisco MJ, Condon J, Sykes PJ, Neoh SH, Morley AA: Detection and quantitation of neoplastic cells in acute lymphoblastic leukemia, by use of the polymerase chain reaction. Br J Haematol 79:211, 1991
10. Kiyoi H, Naoe T, Kitamura K, Yamauchi T, Ichihashi T, Ohno R: Disappearance of minimal residual lymphoblastic leukemia cells in six months after allogeneic bone marrow transplantation without GVHD. Bone Marrow Transplant 8:59, 1991
11. Yokota S, Hansen-Hagge TE, Ludwig W-D, Reiter A, Raghavachar A, Kleihauer E, Bartram CR: Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients. Blood 77:331, 1991
12. Veelken H, Tycko B, Sklar J: Sensitive detection of clonal antigen receptor gene rearrangement for the diagnosis and monitoring of lymphoid neoplasms by a polymerase chain reaction-mediated ribonuclease protection assay. Blood 78:1318, 1991
13. Neale GAM, Menarguez J, Kitchingman GR, Fitzgerald TJ, Koehler M, Mirro J, Jr, Goorha RM: Detection of minimal residual disease in T-cell acute lymphoblastic leukemia using polymerase chain reaction predicts impending relapse. Blood 78:739, 1991
14. Wasserman R, Galili N, Ito Y, Silber JH, Reichard BA, Shane S, Womer RB, Lange B, Rovera G: Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia. J Clin Oncol 10:1879, 1992
15. Brisco MJ, Condon J, Hughes E, Neoh S-H, Sykes PJ, Seshadri R, Toogood I, Waters K, Tauro G, Ekert H, Morley AA: Outcome prediction in childhood acute lymphoblastic leukemia by molecular quantification of residual disease at the end of induction. Lancet 343:196, 1994
16. Sykes PJ, Neoh SH, Brisco MJ, Hughes E, Condon J, Morley AA: Quantitation of targets for PCR by use of limiting dilution. Biotechniques 13:444, 1992
17. Hoelzer DF: Therapy of the newly diagnosed adult with acute lymphoblastic leukemia. Hematol Oncol Clin North Am 7:161, 1993
18. Bradstock KF, Enno A, O'Gorman-Hughes D, Tschuchnigg M, Koutts J, Robertson TI, Lee CH, Selson M, Vowels M: Treatment results in adolescent and adult acute lymphoblastic leukemia using a uniform chemotherapy protocol. Leuk Lymphoma 4:317, 1991
19. Ralph QM, Brisco JM, Joshua DE, Brown R, Gibson J, Morley AA: Advancement of multiple myeloma from diagnosis through plateau phase to progression does not involve a new B-cell clone: Evidence from the immunoglobulin heavy chain gene. Blood 82:202, 1993
20. Ouspenskaia MV, Johnston DA, Roberts WM, Estrov Z, Zipf TF: Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: A description of the method and the principles involved. Leukemia 9:321, 1995
21. Henry JA, Sykes PJ, Brisco MJ, To LB, Juttner CA, Morley AA: Comparison of myeloma cell contamination of bone marrow and peripheral blood stem cell harvests. Br J Haematol 92:614, 1996
22. Cronkite EP: Kinetics of granulopoiesis. Baillieres Clin Haematol 8:351, 1979
23. McGahon A, Bissonnette R, Schmitt M, Cotter KM, Green DR, Cotter TG: BRC-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood 83:1179, 1994
24. Pieters R, Huismans DR, Loonen AH, Hählen K, Van Der Does-Van Den Berg A, Van Wering ER, Veerman AJP: Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukemia. Lancet 338:399, 1991
25. Miller DR, Coccia PF, Bleyer WA, Lukens JN, Siegel SE, Sather HN, Hammond GD: Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: A report from the Children's Cancer Study Group. J Clin Oncol 7:1807, 1989
26. Hoelzer D, Thiel E, Löffler H, Bodenstein H, Plaumann L, Büchner T, Urbanitz D, Koch P, Heimpel H, Engelhardt R, Müller U, Wendt F-C, Sodomann H, Rühl H, Herrmann F, Kaboth W, Dietzfelbinger H, Pralle H, Lunscken Ch, Hellriegel K-P, Spors S, Nowrousian RM, Fischer J, Fülle H, Mitrou PS, Pfreundschuh M, Görg Ch, Emmerich B, Queisser W, Meyer P, Labedzki L, Essers U, König H, Mainzer K, Herrmann R, Messerer D, Zwingers T: Intensified therapy in acute lymphoblastic and acute undifferentiated leukemia in adults. Blood 64:38, 1984
27. Clarkson B, Ellis S, Little C, Gee T, Arlin Z, Mertelsmann R, Andreeff M, Kempin S, Koziner B, Chaganti R: Acute lymphoblastic leukemia in adults. Semin Oncol 12:160, 1985
28. Sebban C, Browman GP, Lepage E, Fière D: Prognostic value of early response to chemotherapy assessed by the day 15 bone marrow aspiration in adult acute lymphoblastic leukemia: A prospective analysis of 437 cases and its application for designing induction chemotherapy trials. Leuk Res 19:861, 1995
29. Hoelzer D: Acute lymphoblastic leukemia - progress in children, less in adults. N Engl J Med 329:1343, 1993
30. Nizet Y, Van Daele S, Lewalle P, Vaerman JL, Philippe M, Vermylen C, Cornu G, Ferrant A, Michaux JL, Martial P: Long-term follow-up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogenic IgH probes and the polymerase chain reaction. Blood 82:1618, 1993
31. Salo A, Pakkala S, Jansson S-E, Helminen P, Palotie A: Monitoring of adult B-cell lineage acute lymphoblastic leukemia: Validation of a simple method for detecting immunoglobulin heavy chain gene clonality. Leukemia 7:1459, 1993
32. Cole-Sinclair M, Foroni L, Wright F, Mehta A, Prentic HG, Hoffbrand AV: Minimal residual disease in acute lymphoblastic leukemia - PCR analysis of immunoglobulin gene rearrangements. Leuk Lymphoma 11:49, 1993 (suppl 2)
33. Beishuizen A, Hahlen K, van Wering ER, van Dongen JJM: Detection of minimal residual disease in childhood leukemia with the polymerase chain reaction. N Engl J Med 324:772, 1993
34. H gene rearrangement events can modify the immunoglobulin heavy chain during progression of B-lineage acute lymphoblastic leukemia. Blood 79:223, 1992
35. Marshall GM, Kwan E, Haber M, Brisco MJ, Sykes PJ, Morley AA, Toogood I, Waters K, Tauro G, Ekert H, Norris MD: Characterisation of clonal immunoglobulin heavy chain and T-cell receptor γ gene rearrangements for evolution at relapse in childhood acute lymphoblastic leukemia. Leukemia 9:1847, 1995